View of Safety profile of Trastuzumab deruxtecan in patients with advanced HER2+ breast cancer: an active pharmacovigilance study

Return to Article Details Safety profile of Trastuzumab deruxtecan in patients with advanced HER2+ breast cancer: an active pharmacovigilance study Download Download PDF